These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
60 related articles for article (PubMed ID: 5877880)
1. [On the existance of the flagellate form of Leishmania donovani in the tissues of the vertebrate host]. Bossie-Agavriloaei A; Lupaşco G Arch Roum Pathol Exp Microbiol; 1965 Sep; 24(3):709-12. PubMed ID: 5877880 [No Abstract] [Full Text] [Related]
2. Appearance of Leishmania donovani (Kenya strain) in the blood of experimentally infected golden hamsters (Mesocricetus auratus). Van Joost KS; Sluiters JF Trop Geogr Med; 1972 Sep; 24(3):292-7. PubMed ID: 4636103 [No Abstract] [Full Text] [Related]
3. Status of glutathione in lymphoid tissues of golden hamster during Leishmania donovani infection. Goyal N; Guru PY; Rastogi AK Indian J Biochem Biophys; 1994 Jun; 31(3):211-3. PubMed ID: 7959849 [TBL] [Abstract][Full Text] [Related]
4. Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis. Samant M; Gupta R; Kumari S; Misra P; Khare P; Kushawaha PK; Sahasrabuddhe AA; Dube A J Immunol; 2009 Jul; 183(1):470-9. PubMed ID: 19542458 [TBL] [Abstract][Full Text] [Related]
5. Experimental infection of animals with leptomonads of Leishmania donovani. Effect of cortisone on the infection in hamster and mouse. Hashimoto I; Ilardi A Ann Ist Super Sanita; 1970; 6(4):257-69. PubMed ID: 5508161 [No Abstract] [Full Text] [Related]
6. [Detection of Leishmania infantum MON-24 in the dog]. Benikhlef R; Harrat Z; Toudjine M; Djerbouh A; Bendali-Braham S; Belkaid M Med Trop (Mars); 2004; 64(4):381-3. PubMed ID: 15615393 [TBL] [Abstract][Full Text] [Related]
7. Relative insensitivity of a Kenyan strain of Leishmania donovani to pentavalent antimony therapy in hamsters. Hanson WL; Waits VB; Hendricks LD; Hockmeyer WT; Davidson DE; Chapman WL J Parasitol; 1983 Apr; 69(2):446-7. PubMed ID: 6854484 [No Abstract] [Full Text] [Related]
8. Immunoprophylaxis against kala-azar. IV (b). Immunization of golden hamsters against Leishmania donovani. Jalees S; Jalil S; Topa PK; Hussain QZ J Commun Dis; 1983 Dec; 15(4):235-41. PubMed ID: 6609188 [No Abstract] [Full Text] [Related]
9. Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis. Garg R; Gupta SK; Tripathi P; Hajela K; Sundar S; Naik S; Dube A Vaccine; 2006 Apr; 24(15):2900-9. PubMed ID: 16448729 [TBL] [Abstract][Full Text] [Related]
10. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10. Bhaumik SK; Naskar K; De T Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771 [TBL] [Abstract][Full Text] [Related]
11. [Experimental transmission of the causative agent of visceral leishmaniasis, Leishmania donovani, to golden hamsters by Phlebotomus longiductus, Parr. 1928 and Phlebotomus smirnovi, Perf. 1941 sandflies]. Strelkova MV; Dergacheva TI; Alekseev AN; Passova OM Med Parazitol (Mosk); 1982; 51(3):49-54. PubMed ID: 7121405 [No Abstract] [Full Text] [Related]
12. Effect of passage level in the immunization of Hissar strain albino mice with EH9 strain against Leishmania donovani. Jalees S; Jalil S; Nangia U; Hussain QZ; Topa PK J Commun Dis; 1984 Dec; 16(4):295-8. PubMed ID: 6535787 [No Abstract] [Full Text] [Related]
13. Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis. Kumari S; Samant M; Misra P; Khare P; Sisodia B; Shasany AK; Dube A Vaccine; 2008 Oct; 26(45):5700-11. PubMed ID: 18762224 [TBL] [Abstract][Full Text] [Related]
15. Vaccination with a novel recombinant Leishmania antigen plus MPL provides partial protection against L. donovani challenge in experimental model of visceral leishmaniasis. Bhardwaj S; Vasishta RK; Arora SK Exp Parasitol; 2009 Jan; 121(1):29-37. PubMed ID: 18983842 [TBL] [Abstract][Full Text] [Related]
16. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. Melby PC; Yang J; Zhao W; Perez LE; Cheng J Infect Immun; 2001 Aug; 69(8):4719-25. PubMed ID: 11447143 [TBL] [Abstract][Full Text] [Related]
17. Course of infection of Leishmania donovani in hamsters inoculated by the intraperitoneal route. Ott KJ; Hanson WL; Stauber LA J Parasitol; 1967 Jun; 53(3):641-5. PubMed ID: 6026857 [No Abstract] [Full Text] [Related]
18. Refractoriness of domestic cats to infection with a Kenyan strain of Leishmania donovani. Anjili CO; Githure JI East Afr Med J; 1993 May; 70(5):322. PubMed ID: 8306914 [No Abstract] [Full Text] [Related]